Developing a contact center relationship is an investment of time, energy, and finance that can yield countless returns if the relationship is valued and viewed as a partnership. Building trust…
Dr. Maria Anitan, Global Head of Pharmacovigilance and Drug Safety, and our knowledgeable PV Quality Manager Ana Augusto are representing Med Communications at the European Pharmacovigilance Congress this week. One of the most…
A small biopharmaceutical client needed a call center and assistance with the launch of a rare disease product. They had a limited budget, a two-person Med Affairs team, and only…
Pharmaceutical companies strive to ensure that the right patients have access to their products through appropriate coverage from drug coverage plans (Payors). Payors have well-established procedures for carefully considering the…
Managed care organizations and health care decision-makers use AMCP formulary dossiers for formulary and medical policy considerations regarding coverage or reimbursement. This type of dossier is a comprehensive collection of…
Promotional review is traditionally accomplished by utilizing groups of professionals that meet a few times per week to review assets. It generally takes several weeks to approve an asset, and…
If you are attending the World Drug Safety Congress Americas in Boston next week, be sure to check out the talk our global head of pharmacovigilance and drug safety, Dr….
One of Med Communications’ clients, a Top 10 pharmaceutical manufacturer, asked for assistance in implementing a new component authoring platform for content creation and management. This platform would allow for…
Standard responses (SRs) are reactive documents that are frequently used in the pharmaceutical industry to reply to unsolicited medical inquiries from health care professionals (HCPs). SRs provide fair, balanced, accurate,…
Founder and CEO, Dr. Allen Scoggin, shares the history of Med Communications and honors the path the company has taken in becoming a trusted, leading provider of medical affairs services…
